Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
11.02
-0.75 (-6.37%)
At close: Nov 5, 2026, 4:00 PM EST
11.43
+0.41 (3.72%)
After-hours: Nov 5, 2026, 7:30 PM EST
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.86 billion as of November 5, 2026. It is the 6,834th most valuable company in the world and the 1,793rd biggest in the United States. Its market cap has increased by 155.69% in one year.
Market Cap
1.86B
Enterprise Value
1.49B
1-Year Change
155.69%
Global Rank
Country Rank
#1,793 United States
Category
ChartMarket Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.86B, an increase of 21.58%. That is a compound annual growth rate of 2.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 1.86B | 122.08% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemab Therapeutics Holdings | 2.11B |
| First Tracks Biotherapeutics | 2.06B |
| Fortrea Holdings | 2.01B |
| Sarepta Therapeutics | 2.01B |
| Maravai LifeSciences Holdings | 2.00B |
| Harmony Biosciences Holdings | 2.00B |
| Trevi Therapeutics | 1.99B |
| Replimune Group | 1.96B |